Catherine Tangen

11PUBLICATIONS
181CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied geophysicsEnvironmental epidemiologyChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 05, 2024
DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 Trial.

Gopa Iyer, Catherine M Tangen, Michal Sarfaty

|Sep 10, 2024
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma.

Pedro Barata, Catherine Tangen, Melissa Plets

|Jun 14, 2024
Reply to J.A. Garcia et al.

Susan Halabi, Siyuan Guo, Akash Roy

|Jan 05, 2024
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer.

Susan Halabi, Akash Roy, Larysa Rydzewska

|Dec 19, 2023
Genome-Wide Gene-Environment Interaction Analyses to Understand the Relationship between Red Meat and Processed Meat Intake and Colorectal Cancer Risk.

Mariana C Stern, Joel Sanchez Mendez, Andre E Kim

|Nov 15, 2023
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.

Seth P Lerner, David J McConkey, Catherine M Tangen

Pageof 2

Frequent Collaborators

3 joint publications

Stephanie A Bien

3 joint publications

Maha Hussain

3 joint publications

Demetrius Albanes

3 joint publications

Sonja I Berndt